NCT00003193View on ClinicalTrials.gov

Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Head and Neck CancerOral Complications
Interventions
DRUG

amifostine trihydrate

DRUG

paclitaxel

PROCEDURE

conventional surgery

RADIATION

radiation therapy

Trial Locations (2)

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00003193 - Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer | Biotech Hunter | Biotech Hunter